MX2022007670A - Compuestos antihelminticos que comprenden una estructura de quinolina. - Google Patents

Compuestos antihelminticos que comprenden una estructura de quinolina.

Info

Publication number
MX2022007670A
MX2022007670A MX2022007670A MX2022007670A MX2022007670A MX 2022007670 A MX2022007670 A MX 2022007670A MX 2022007670 A MX2022007670 A MX 2022007670A MX 2022007670 A MX2022007670 A MX 2022007670A MX 2022007670 A MX2022007670 A MX 2022007670A
Authority
MX
Mexico
Prior art keywords
anthelmintic compounds
quinoline structure
compounds
dirofilaria
anthelmintic
Prior art date
Application number
MX2022007670A
Other languages
English (en)
Inventor
Michael Berger
Michael Linder
Carolin Schneider
Janina Tänzler
Ulrich Sondern
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2022007670A publication Critical patent/MX2022007670A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a nuevos compuestos antihelmínticos. Estos compuestos se pueden usar por ejemplo en el tratamiento del tipo de helmintiasis causados por helmintos tal como Dirofilaria, en particular Dirofilaria immitis.
MX2022007670A 2019-12-18 2020-12-17 Compuestos antihelminticos que comprenden una estructura de quinolina. MX2022007670A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19217685 2019-12-18
EP20213298 2020-12-11
PCT/EP2020/086666 WO2021122911A1 (en) 2019-12-18 2020-12-17 Anthelmintic compounds comprising a quinoline structure

Publications (1)

Publication Number Publication Date
MX2022007670A true MX2022007670A (es) 2022-07-19

Family

ID=74130185

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022007670A MX2022007670A (es) 2019-12-18 2020-12-17 Compuestos antihelminticos que comprenden una estructura de quinolina.

Country Status (9)

Country Link
US (1) US20230148316A1 (es)
EP (1) EP4077281A1 (es)
JP (1) JP2023507173A (es)
CN (1) CN114845994A (es)
AU (1) AU2020406093A1 (es)
BR (1) BR112022012126A2 (es)
CA (1) CA3164098A1 (es)
MX (1) MX2022007670A (es)
WO (1) WO2021122911A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020191091A1 (en) 2019-03-19 2020-09-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
BR112022024156A2 (pt) 2020-05-29 2023-02-14 Boehringer Ingelheim Animal Health Usa Inc Compostos heterocílicos antelmínticos
AU2022377394A1 (en) 2021-11-01 2024-06-13 Boehringer Ingelheim Vetmedica Gmbh Anthelmintic pyrrolopyridazine compounds

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000964A1 (en) 1990-07-05 1992-01-23 Nippon Soda Co., Ltd. Amine derivative
US5399582A (en) 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
US6221894B1 (en) 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
WO1996029073A1 (en) 1995-03-20 1996-09-26 Merck & Co., Inc. Nodulisporic acid derivatives
US5595991A (en) 1995-03-20 1997-01-21 Merck & Co., Inc. Anthelmintic use of nodulisporic acid and analogs thereof
US5962499A (en) 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
US5834260A (en) 1996-08-30 1998-11-10 Merck & Co., Inc. Antiparasitic agents
AU2004312506B2 (en) 2003-12-31 2011-08-04 Schering-Plough Pty. Limited Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives
US7361689B2 (en) 2003-12-31 2008-04-22 Schering-Plough Animal Health Corporation Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof
CN101065352A (zh) 2004-09-23 2007-10-31 先灵-普劳有限公司 使用新的三氟甲磺酰苯胺肟醚衍生物控制动物中的寄生虫
DE602005017419D1 (de) 2004-11-19 2009-12-10 Schering Plough Ltd Kontrolle von parasiten bei tieren mittels verwendung von parasitiziden 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitril-derivaten
PE20070108A1 (es) 2005-06-09 2007-02-09 Schering Plough Ltd Control de parasitos en animales con derivados de n-[(feniloxi)fenil]-1,1,1-trifluorometansulfonamida y de n-[(fenilsulfanil)fenil]-1,1,1-trifluorometansulfonamida
DE102006015470A1 (de) 2006-03-31 2007-10-04 Bayer Cropscience Ag Substituierte Enaminocarbonylverbindungen
WO2010053517A2 (en) 2008-10-29 2010-05-14 Aroian Raffi V Combination therapy to combat helminth resistance
US8007761B2 (en) 2008-12-24 2011-08-30 Praxair Technology, Inc. Carbon dioxide emission reduction method
TWI696615B (zh) 2016-05-05 2020-06-21 瑞士商伊蘭科動物健康公司 雜芳基-1,2,4-三唑及雜芳基-三唑化合物
JP7165129B2 (ja) 2016-11-11 2022-11-02 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 新規な駆虫性キノリン－３－カルボキサミド誘導体
KR20200036909A (ko) 2017-08-04 2020-04-07 바이엘 애니멀 헬스 게엠베하 연충에 의한 감염을 치료하기 위한 퀴놀린 유도체
MX2020009320A (es) 2018-03-08 2020-10-07 Bayer Ag Uso de compuestos heteroarilo-triazol y heteroarilo-tetrazol como plaguicidas para la proteccion de plantas.
US20210147387A1 (en) 2018-04-12 2021-05-20 Bayer Aktiengesellschaft Novel heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides
UY38184A (es) 2018-04-17 2019-10-31 Bayer Ag Compuestos heteroarilo-triazol y heteroarilo-tetrazol novedosos como plaguicidas
FI3919486T3 (fi) 2018-04-25 2023-08-23 Bayer Ag Uusia heteroaryylitriatsoli- ja heteroaryylitetratsoliyhdisteitä torjunta-aineina
CN112087951A (zh) 2018-05-08 2020-12-15 先正达农作物保护股份公司 施用某一种或多种杂芳基-1,2,4-三唑和杂芳基-四唑化合物来控制对植物、其繁殖材料和植物衍生产品的损害的方法
TW202023386A (zh) 2018-09-13 2020-07-01 瑞士商先正達合夥公司 殺有害生物活性唑-醯胺化合物
TW202019901A (zh) 2018-09-13 2020-06-01 瑞士商先正達合夥公司 殺有害生物活性唑-醯胺化合物
ES2958917T3 (es) 2018-10-02 2024-02-16 Syngenta Participations Ag Compuestos de benceno-amida y azina-amida con actividad plaguicida
JP2022505376A (ja) 2018-10-19 2022-01-14 シンジェンタ パーティシペーションズ アーゲー 殺有害生物活性アゾール－アミド化合物
EP3877380A1 (en) 2018-11-05 2021-09-15 Syngenta Participations Ag Pesticidally active azole-amide compounds
CA3122106C (en) * 2018-12-18 2024-05-28 Elanco Tiergesundheit Ag Bicyclic derivatives
EP3696175A1 (en) 2019-02-18 2020-08-19 Syngenta Crop Protection AG Pesticidally active azole-amide compounds
US20220213063A1 (en) 2019-03-22 2022-07-07 Syngenta Crop Protection Ag N-[l-(5-BROMO-2-PYRIMIDIN-2-YL-1,2,4-TRIAZOL-3-YL)ETHYL]-2-CYCLOPROPYL-6-(TRIFLUOROMETHYL)PYRIDINE-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INSECTICIDES
TW202102489A (zh) 2019-03-29 2021-01-16 瑞士商先正達農作物保護公司 殺有害生物活性之二𠯤-醯胺化合物
MA55500A (fr) 2019-04-05 2022-02-09 Syngenta Crop Protection Ag Composés de diazine-amide à action pesticide
JP2022528181A (ja) 2019-04-11 2022-06-08 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト 殺有害生物的に有効なジアジン－アミド化合物
EP3725788A1 (en) 2019-04-15 2020-10-21 Bayer AG Novel heteroaryl-substituted aminoalkyl azole compounds as pesticides
US11505548B2 (en) 2019-04-26 2022-11-22 Celgene Corporation Heterocyclic compounds and their use for treatment of helminthic infections and diseases

Also Published As

Publication number Publication date
AU2020406093A1 (en) 2022-06-16
US20230148316A1 (en) 2023-05-11
CA3164098A1 (en) 2021-06-24
CN114845994A (zh) 2022-08-02
WO2021122911A1 (en) 2021-06-24
JP2023507173A (ja) 2023-02-21
EP4077281A1 (en) 2022-10-26
BR112022012126A2 (pt) 2022-08-30

Similar Documents

Publication Publication Date Title
MX2022007670A (es) Compuestos antihelminticos que comprenden una estructura de quinolina.
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
EA201800367A1 (ru) Способы лечения болезни хантингтона
MX2022007671A (es) Compuestos antihelminticos que comprenden una estructura de azaindoles.
MX2020011449A (es) Oxiesteroles y metodos de uso de los mismos.
EA201990240A1 (ru) Новые трициклические соединения в качестве противораковых средств
EA201690153A1 (ru) Замещенные бензофуранильные и бензоксазолильные соединения и их применения
MY197698A (en) Oxysterols and methods of use thereof
PH12017501160A1 (en) 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis
MX2023006744A (es) Compuestos antihelminticos que comprenden una estructura de tienopiridina.
PH12019502363A1 (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds
MX2022000945A (es) Composicion para incrementar la expresion de pgc-1alfa.
PH12017501133A1 (en) Pyrazolopyridinamines
EA201791058A1 (ru) Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4)
PH12019500467A1 (en) Benzo-fused heterocyclic derivatives useful agonists of gpr120
TW201613878A (en) Pyrazine GPR40 agonists for the treatment of type II diabetes
CR20210460A (es) Compuestos útiles en la terapia del vih
EA201691962A1 (ru) Амидозамещенные азольные соединения в качестве ингибиторов tnks1 и/или tnks2
MX2020006434A (es) Nuevos compuestos inhibidores del blanco mecanistico de rapamicina (mtor).
EA201791432A1 (ru) Композиции на основе пролекарства монометилфумарата
MX2017013099A (es) Metodos para el tratamiento de trastornos inflamatorios.
EA201500736A1 (ru) Пиразолилкарбоксамиды i в качестве ингибиторов crac каналов
EA201500737A1 (ru) Пиразолилкарбоксамиды ii в качестве ингибиторов crac каналов
TN2018000157A1 (en) Sodium channel blocker
EA201291384A1 (ru) Терапевтические агенты 976